Automated Detection of Lung Cancer Levels Based on Patient’s Lifestyle Information
Abstract
Lung cancer begins in the lungs, where cells grow out of control to create tumors. Lung cancer is one of the major causes of cancer-related deaths globally. With less than 20% of cases surviving for five years, prompt and precise detection is essential. This study discusses the shortcomings of the existing medical screening protocols as well as the length of time needed to discover lung cancer stages. The project aims to create an automated system that uses lifestyle data from cancer patients to accurately identify the cancer level, reducing the possibility of human mistakes and speeding up the diagnostic procedure. Based on answers to lifestyle health questions like diet, obesity, smoking habits, passive smoking, chest pain, and bloody coughing, the algorithm predicts the level of lung cancer. To build the prediction system, two machine learning classifiers are used with a dataset containing medical records of 1,000 patients who have lung cancer. The approach involved loading data from an Excel file into MATLAB and using cross-validation for precise model creation. The process is followed by constructing a confusion matrix and then extracting performance metrics from it including accuracy, recall, and F1-score. The first model achieved a classification accuracy of 96% using the Support Vector Machine classifier, which was further improved to 100% using the Error-Correcting Output Codes (ECOC) model. Additionally, a Lung Cancer Level Prediction web application is developed…
Read the paper
Related studies
- Tobacco and COPD: presenting the World Health Organization (WHO) Tobacco Knowledge Summary
- Comparative effects of e-cigarette smoking on periodontal status, salivary pH, and cotinine levels
- Association between exposure to environmental pollutants and increased oral health risks, a comprehensive review
- Influence of gestational window on offspring vascular health in rodents with in utero exposure to electronic cigarettes
- Natural products as kinase inhibitors in lung cancer: molecular mechanisms, therapeutic potential, and clinical trials
- Nicotine in electronic cigarettes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.